fluorouracil has been researched along with Granuloma, Hodgkin in 34 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eleven patients with osteogenic sarcoma (9), Hodgkin disease (1), and mesenchymal sarcoma (1), were treated with 5-fluorouracil (5-FU) and cisplatin (DDP)." | 3.66 | 5-fluorouracil and cis-platinum in the treatment of refractory solid tumors: a pediatric oncology group phase I-II study. ( Chan, R; Dyment, PG; Land, VJ; Starling, K; Strandjord, SE, 1981) |
| "Treatment of both Hodgkin's disease (HD) and high-grade non-Hodgkin's lymphoma (HG-NHL) with bulky presentation at diagnosis frequently results in residual masses detected radiologically." | 2.68 | Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma. ( Babini, L; Barbieri, E; Battista, G; Bendandi, M; Canini, R; Fanti, S; Frezza, G; Gherlinzoni, F; Gozzetti, A; Merla, E; Monetti, N; Pisi, P; Rimondi, MR; Tura, S; Zinzani, PL; Zompatori, M, 1996) |
| "From 23 patients with advanced non-Hodgkin lymphomas of a high malignancy 11 received a therapy with CVPP scheme; 2 of them came into a complete remission and 3 of them into a partial one." | 2.65 | [The so-called partial synchronization in the treatment of malignant lymphomas. A clinical study]. ( Anger, G; Fink, R; Höche, D, 1980) |
| "The most frequent pathologies were Hodgkin's lymphoma and breast cancer." | 1.62 | Evaluation of ovarian reserve before and after chemotherapy. ( Ayadi, M; Bahri, O; Berjeb, KK; Braham, M; Chakroun, N; Chtourou, S; Debbabi, L; Fadhlaoui, A; Hamdoun, M; Hannachi, H; Kacem, K; Zemni, Z; Zhioua, F, 2021) |
| "The history of cancer chemotherapy and of the discipline of medical oncology has been that of drug discovery." | 1.34 | The contribution of Gianni Bonadonna to the history of chemotherapy. ( Ribatti, D, 2007) |
| "Neoadjuvant chemotherapy in Hodgkin's disease has improved survival time and tolerance to irradiation, allowing a lowering of the total doses used and the volumes irradiated." | 1.28 | [Radiotherapy with neoadjuvant chemotherapy]. ( Alapetite, C; Baillet, F; Dessard-Diana, B; Housset, M; Jacquillat, C; Michel-Langlet, P, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (73.53) | 18.7374 |
| 1990's | 3 (8.82) | 18.2507 |
| 2000's | 1 (2.94) | 29.6817 |
| 2010's | 4 (11.76) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Berjeb, KK | 1 |
| Debbabi, L | 1 |
| Braham, M | 1 |
| Zemni, Z | 1 |
| Chtourou, S | 1 |
| Hannachi, H | 1 |
| Hamdoun, M | 1 |
| Ayadi, M | 1 |
| Kacem, K | 1 |
| Zhioua, F | 1 |
| Fadhlaoui, A | 1 |
| Bahri, O | 1 |
| Chakroun, N | 1 |
| Natoli, A | 1 |
| Lüpertz, R | 1 |
| Merz, C | 1 |
| Müller, WW | 1 |
| Köhler, R | 1 |
| Krammer, PH | 1 |
| Li-Weber, M | 1 |
| Lamberth, F | 1 |
| Guilbert, P | 1 |
| Gaillot-Petit, N | 1 |
| Champagne, C | 1 |
| Looten-Vieren, L | 1 |
| Nguyen, TD | 1 |
| Magyari, F | 1 |
| Barna, S | 1 |
| Miltényi, Z | 1 |
| Rajnai, H | 1 |
| Csomor, J | 1 |
| Udvardy, M | 1 |
| Illés, Á | 1 |
| Váróczy, L | 1 |
| Demirci, U | 1 |
| Büyükberber, S | 1 |
| Yilmaz, G | 1 |
| Oztürk, B | 1 |
| Akyürek, N | 1 |
| Yildiz, R | 1 |
| Tonyali, O | 1 |
| Coşkun, U | 1 |
| Benekli, M | 1 |
| BRINDLEY, CO | 1 |
| FALKSON, G | 1 |
| SNYMAN, HJ | 1 |
| KARNOFSKY, DA | 1 |
| MYHRE, K | 1 |
| FJAERLI, J | 1 |
| Ribatti, D | 1 |
| Höche, D | 1 |
| Fink, R | 1 |
| Anger, G | 1 |
| Land, VJ | 1 |
| Dyment, PG | 1 |
| Starling, K | 1 |
| Strandjord, SE | 1 |
| Chan, R | 1 |
| Mah, K | 1 |
| Keane, TJ | 1 |
| Van Dyk, J | 1 |
| Braban, LE | 1 |
| Poon, PY | 1 |
| Hao, Y | 1 |
| Stewart, FM | 1 |
| Temeles, D | 1 |
| Lowry, P | 1 |
| Thraves, T | 1 |
| Grosh, WW | 1 |
| Quesenberry, PJ | 1 |
| Zinzani, PL | 1 |
| Zompatori, M | 1 |
| Bendandi, M | 1 |
| Battista, G | 1 |
| Fanti, S | 1 |
| Barbieri, E | 1 |
| Gherlinzoni, F | 1 |
| Rimondi, MR | 1 |
| Frezza, G | 1 |
| Pisi, P | 1 |
| Merla, E | 1 |
| Gozzetti, A | 1 |
| Canini, R | 1 |
| Monetti, N | 1 |
| Babini, L | 1 |
| Tura, S | 1 |
| Lowenthal, RM | 1 |
| Jestrimski, KW | 1 |
| Baillet, F | 1 |
| Housset, M | 1 |
| Dessard-Diana, B | 1 |
| Jacquillat, C | 1 |
| Michel-Langlet, P | 1 |
| Alapetite, C | 1 |
| Wand, H | 1 |
| Rieche, K | 1 |
| Kobayashi, T | 1 |
| Takatani, O | 1 |
| Hattori, N | 1 |
| Kimura, K | 1 |
| Dendy, PP | 1 |
| Armstrong, JG | 1 |
| Watt, J | 1 |
| Kühböck, J | 1 |
| Pokorny, D | 1 |
| Steinbach, K | 1 |
| Eggerth, G | 1 |
| Copeland, EM | 1 |
| McBride, CM | 1 |
| Frei, E | 1 |
| Schabel, FM | 1 |
| Goldin, A | 1 |
| Wilmanns, W | 1 |
| Carter, SK | 1 |
| Livingston, RB | 1 |
| Alberto, P | 1 |
| Stutzman, L | 1 |
| Clément, F | 1 |
| Kagan, AR | 1 |
4 reviews available for fluorouracil and Granuloma, Hodgkin
| Article | Year |
|---|---|
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast | 1986 |
The use of cytotoxic drugs in the surgery of malignant disease.
Topics: Abdominal Neoplasms; Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Carcinoma, | 1968 |
[Current status of cytostatic therapy].
Topics: Adrenal Cortex Hormones; Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Cyta | 1974 |
Single-agent therapy for Hodgkin's disease.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Carmustine; | 1973 |
5 trials available for fluorouracil and Granuloma, Hodgkin
| Article | Year |
|---|---|
[The so-called partial synchronization in the treatment of malignant lymphomas. A clinical study].
Topics: Bleomycin; Cell Division; Clinical Trials as Topic; Cytarabine; Doxorubicin; Fluorouracil; Hodgkin D | 1980 |
Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Combined Modality | 1994 |
Post-5-fluorouracil human marrow: stem cell characteristics and renewal properties after autologous marrow transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carmustine | 1993 |
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Combined radiotherapy and chemotherapy of lymphomas and other cancers.
Topics: Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Fluorouracil; Follow-Up Studies; Hematopoi | 1971 |
25 other studies available for fluorouracil and Granuloma, Hodgkin
| Article | Year |
|---|---|
Evaluation of ovarian reserve before and after chemotherapy.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 2021 |
Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Cell Line, | 2013 |
[Potential indications for helical tomotherapy in breast cancers].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brea | 2014 |
Histopathological difficulties in an adolescent lymphoma patient.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluoroura | 2015 |
Coexistence Hodgkin's lymphoma and colonic adenocarcinoma: a case report.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capecitabine; Colonic | 2010 |
METHODOLOGY OF PRELIMINARY CHEMOTHERAPEUTIC TRIALS IN PATIENTS WITH MALIGNANT SOLID TUMORS.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Colonic Neoplasms; Cyclophosp | 1963 |
EXPERIENCE WITH CHEMOTHERAPY OF CANCER AT THE UNIVERSITY OF PRETORIA.
Topics: Antineoplastic Agents; Aziridines; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Fluorouracil; H | 1964 |
NONSURGICAL TREATMENT OF PULMONARY CANCER.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agen | 1964 |
TREATMENT OF MALIGNANT TUMOURS WITH 5-FLUOROURACIL IN 80 PATIENTS.
Topics: Biomedical Research; Breast Neoplasms; Colonic Neoplasms; Drug Therapy; Esophageal Neoplasms; Female | 1964 |
The contribution of Gianni Bonadonna to the history of chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; | 2007 |
5-fluorouracil and cis-platinum in the treatment of refractory solid tumors: a pediatric oncology group phase I-II study.
Topics: Adolescent; Adult; Child; Cisplatin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Co | 1981 |
[Stomach neoplasms].
Topics: Aftercare; Eosinophilic Granuloma; Fluorouracil; Gastrectomy; Hodgkin Disease; Lymph Nodes; Mitomyci | 1978 |
[Radiotherapy with neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Doxorub | 1989 |
[The effect of cytostatic drugs on blood platelets and lymphocytes in patients with neoplasms].
Topics: Adenine Nucleotides; Adenosine Diphosphate; Amidines; Antibiotics, Antineoplastic; Bleomycin; Blood | 1974 |
Echographic evaluation of abdominal tumor regression during antineoplastic treatment.
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorub | 1974 |
Responses of freshly cultured tumour cells to certain selected chemotherapeutic agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Chlorambucil; Colchicine; Culture Techniques; Cyclophosphamid | 1968 |
Current problems in the use of the oncolytic drugs.
Topics: Antineoplastic Agents; Busulfan; Carcinoma, Squamous Cell; Child; Chlorambucil; Choriocarcinoma; Dac | 1968 |
[Polychemotherapy of malignant tumors and hemoblastoses].
Topics: Adenocarcinoma; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Bronchial Neoplasms; Carcinom | 1968 |
Axillary metastases from unknown primary sites.
Topics: Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Squamous Cel | 1973 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara | 1974 |
Advanced cancer: New concepts of medical therapy.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Choriocarcinoma; Colonic Neopl | 1973 |
[Progress in chemotherapy of solid tumors and malignant lymphomas (continued)].
Topics: Adult; Antineoplastic Agents; Carcinoma; Choriocarcinoma; Female; Fluorouracil; Gonadal Steroid Horm | 1967 |
Cytotoxic agents in the treatment of malignant disease.
Topics: Antimetabolites; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Chlorambucil; Choriocarcinoma; | 1968 |
[The chemotherapy of cancer].
Topics: Adult; Alkylating Agents; Antimetabolites; Antineoplastic Agents; Dactinomycin; Female; Fluorouracil | 1967 |
Comments on morbidity in present-day radiotherapy.
Topics: Breast Neoplasms; Buttocks; Carcinoma, Squamous Cell; Dactinomycin; Erythema; Female; Fluorouracil; | 1971 |